Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441012
Status:
COMPLETED
Last Update Posted:
2015-03-19
First Post:
2007-02-26
Brief Title:
Study of Modified Process HibHep B Vaccine in Infants V121-019COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Study in Healthy Infants of the Safety Tolerability and Immunogenicity of Haemophilus Influenzae Type bHepatitis B Vaccine Manufactured With a Modified Process
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine if there is an improvement in the immune response to HBsAg hepatitis B virus in healthy infants using a modified process in a combination Haemophilus Influenzae type bHepatitis B vaccine and a currently licensed Haemophilus Influenzae type bHepatitis B vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_513 | None | None | None |